Related Experiment Videos

Leveraging Kinesin Family as Key Regulators of Malignant Progression and the Immunometabolic Niche for Precision

Leyi Li1, Jing Li1, Xinyi Zhao1

  • 1Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China.

Technology in Cancer Research & Treatment
|July 21, 2026
PubMed

Insights

Kinesin family (KIF) proteins regulate cell division and signaling, impacting tumor growth and the immune microenvironment. Targeting KIFs offers a promising strategy for precision cancer therapy and developing new anticancer drugs.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Medicine

Background:

  • Malignant tumors represent a significant global health challenge, necessitating novel therapeutic targets for precision medicine.
  • Kinesin family (KIF) proteins are essential microtubule motor proteins involved in crucial cellular functions like transport and division.
  • Dysregulated KIF expression is increasingly recognized for its role in tumor metabolism and immune microenvironment modulation, driving cancer proliferation.

Purpose of the Study:

  • To synthesize current mechanistic insights into how KIFs regulate tumors.
  • To evaluate the potential of KIFs as therapeutic targets and biomarkers for precision cancer therapy.
  • To review the clinical progress of KIF-targeted inhibitors in various cancer types.

Main Methods:

  • Literature review and synthesis of recent research on KIF function in cancer.
  • Analysis of KIFs' roles in tumor metabolism and immune microenvironment.
  • Evaluation of translational potential for KIF-targeted therapies and biomarkers.

Main Results:

  • KIFs are implicated in regulating tumor metabolism and reshaping the tumor immune microenvironment.
  • Aberrant KIF expression is linked to uncontrolled tumor cell proliferation.
  • KIF-targeted inhibitors are progressing through clinical trials for multiple cancer types.

Conclusions:

  • Kinesin family proteins are critical regulators of tumor progression.
  • Targeting KIFs presents a promising avenue for developing next-generation precision cancer therapies.
  • KIF inhibitors show potential as novel anticancer agents to combat tumor growth and progression.
Keywords:
anti-cancer therapy resistancecancer progressionkinesin familymetabolic reprogrammingtumor immune microenvironment

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...